Lakeside Holding (LSH) is pleased to announce that its wholly owned subsidiary, Hupan Pharmaceutical Co., has entered into two distribution agreements with Hubei Kelun Pharmaceutical Trading Co., Ltd., a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd., a publicly traded company on the Shenzhen Stock Exchange, principally engaged in the research and development, manufacture and distribution of pharmaceutical products. Under the agreements, Hupan Pharmaceutical will distribute basic large-volume parenteral solutions, along with related medical products and equipment, to healthcare institutions across China. The agreements, effective from January 1, 2025, to December 31, 2025, further expand Hupan Pharmaceutical’s portfolio of medical distribution clients.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio